Browsing by Author "Heuvel, M. van den"

Now showing items 1-50 of 60

Programmed Cell Death-1/ Ligand-1 PET Imaging A Novel Tool to Optimize Immunotherapy?
Verhoeff, S.R. ; Heuvel, M. van den ; Herpen, C.M.L. van ; Piet, B.; Aarntzen, E.H.J.G. ; Heskamp, S.
2020, Article / Letter to editor (Pet Clinics, vol. 15, iss. 1, (2020), pp. 35-43)
A continuous responder algorithm to optimize clinical management of small-cell lung cancer with progastrin-releasing peptide as a simple blood test
Muley, T.; Zhang, Xiaotong; Holdenrieder, S.; Korse, C.M.; Zhi, X.Y.; Molina, R.; Liu, Zhongjuan; Hartmann, G.; Heuvel, M. van den ; Qian, K.; Marrades, R.; Engel, C.; He, Y.; Wehnl, B.; Dayyani, F.; Herth, F. et al. sine al.
2020, Article / Letter to editor (Tumor Biology, vol. 42, iss. 9, (2020), article 1010428320958603)
Rationale and design of the PRAETORIAN-COVID trial: A double-blind, placebo-controlled randomized clinical trial with valsartan for PRevention of Acute rEspiraTORy dIstress syndrome in hospitAlized patieNts with SARS-COV-2 Infection Disease
Gommans, D.H.F. ; Nas, J. ; Pinto-Sietsma, S.J.; Koop, Y. ; Konst, R.E. ; Mensink, F.B. ; Aarts, G.W.A. ; Konijnenberg, L.S.F. ; Cortenbach, K.R. ; Verhaert, D.V.M. ; Thannhauser, J. ; Mol, J.H.Q. ; Rooijakkers, M.J.P. ; Vos, J.L. ; Rumund, A. van ; Vart, P. ; Hassing, R.J.; Cornel, J.H. ; Jager, C.P.C. de; Heuvel, M. van den ; Hoeven, J.G. van der ; Royen, N. van ; Kimmenade, R.R.J. van et al. sine al.
2020, Article / Letter to editor (American Heart Journal, vol. 226, (2020), pp. 60-68)
Durvalumab With or Without Tremelimumab vs Standard Chemotherapy in First-line Treatment of Metastatic Non-Small Cell Lung Cancer: The MYSTIC Phase 3 Randomized Clinical Trial
Rizvi, N.A.; Cho, B.C.; Reinmuth, N.; Lee, K.H.; Luft, A.; Ahn, M.J.; Heuvel, M. van den ; Cobo, M.; Vicente, D.; Smolin, A.; Moiseyenko, V.; Antonia, S.J.; Moulec, S. Le; Robinet, G.; Natale, R.; Schneider, J.; Shepherd, F.A.; Geater, S.L.; Garon, E.B.; Kim, E.S.; Goldberg, S.B.; Nakagawa, K.; Raja, R.; Higgs, B.W.; Boothman, A.M.; Zhao, L.; Scheuring, U.; Stockman, P.K.; Chand, V.K.; Peters, S. et al. sine al.
2020, Article / Letter to editor (Jama Oncology, vol. 6, iss. 5, (2020), pp. 661-674)
The clinical effectiveness of the COPDnet integrated care model
Koolen, E.H.; Borst, B. van den; Man, M. de; Antons, J.C.; Robberts, B.; Dekhuijzen, P.N.R. ; Vercoulen, J.H.M.M. ; Heuvel, M. van den ; Wees, P.J. van der ; Hul, A.J. van 't
2020, Article / Letter to editor (Respiratory Medicine, vol. 172, (2020), article 106152)
The Validity and Predictive Value of Blood-Based Biomarkers in Prediction of Response in the Treatment of Metastatic Non-Small Cell Lung Cancer: A Systematic Review
Delft, F. von; Koffijberg, H.; Retèl, V.; Heuvel, M. van den ; Ijzerman, M.
2020, Article / Letter to editor (Cancers, vol. 12, iss. 5, (2020), article 1120)
Nivolumab in pre-treated advanced non-small cell lung cancer: long term follow up data from the Dutch expanded access program and routine clinical care
Schouten, Robert D.; Egberink, Lucie; Muller, Mirte; Gooijer, Cornedine J. De; Werkhoven, Erik van; Heuvel, M. van den ; Baas, Paul
2020, Article / Letter to editor (Translational Lung Cancer Research, vol. 9, iss. 5, (2020), pp. 1736-1748)
Presence of a 34-gene signature is a favorable prognostic marker in squamous non-small cell lung carcinoma
Theelen, W.S.M.E.; Krijgsman, O.; Monkhorst, K.; Kuilman, T.; Peters, D.D.G.C.; Cornelissen, S.; Heuvel, M. van den ; Schulze, K.
2020, Article / Letter to editor (Journal of Translational Medicine, vol. 18, iss. 1, (2020), article 271)
Cumulative pemetrexed dose increases the risk of nephrotoxicity
Rouw, H.J.A. de ; Boosman, R.J.; Bruinhorst, H. van de; Biesma, B.; Heuvel, M. van den ; Burger, D.M. ; Hilbrands, L.B. ; Heine, R. ter ; Derijks, H.J.
2020, Article / Letter to editor (Lung Cancer, vol. 146, (2020), pp. 30-35)
Comparability of PD-L1 immunohistochemistry assays for non-small-cell lung cancer: a systematic review.
Koomen, B.M.; Badrising-Soenessardien, S.K.; Heuvel, M. van den ; Willems, S.M.
2020, Article / Letter to editor (Histopathology, vol. 76, iss. 6, (2020), pp. 793-802)
Evaluation of a Hybrid Capture-Based Pan-Cancer Panel for Analysis of Treatment Stratifying Oncogenic Aberrations and Processes
Kroeze, L.; Voer, R.M. de ; Kamping, E.J. ; Rhein, D.T. von ; Jansen, E. ; Hermsen, Mandy J.W.; Heuvel, M. van den ; Grunberg, K.; Ligtenberg, M.J.L.
2020, Article / Letter to editor (Journal of Molecular Diagnostics, vol. 22, iss. 6, (2020), pp. 757-769)
A limited sampling schedule to estimate individual pharmacokinetics of pemetrexed in patients with varying renal functions
Rouw, N. de ; Visser, S.; Koolen, S.L.; Aerts, J.; Heuvel, M. van den ; Derijks, H.J.; Burger, D.M. ; Heine, R. ter
2020, Article / Letter to editor (Cancer Chemotherapy and Pharmacology, vol. 85, iss. 1, (2020), pp. 231-235)
Simple and Rapid Quantification of the Multi-Enzyme Targeting Antifolate Pemetrexed in Human Plasma
Hombergh, E.C.A. van den ; Rouw, N. de ; Heuvel, M. van den ; Croes, S.; Burger, D.M. ; Derijks, J.; Erp, N.P. van ; Heine, R. ter
2020, Article / Letter to editor (Therapeutic Drug Monitoring, vol. 42, iss. 1, (2020), pp. 146-150)
Local and regional treatment response by (18)FDG-PET-CT-scans 4 weeks after concurrent hypofractionated chemoradiotherapy in locally advanced NSCLC
Diessen, Judi N.A. van; Fontaine, Matthew La; Heuvel, M. van den ; Werkhoven, E. van; Walraven, I.; Vogel, W.V.; Belderbos, J.S.; Sonke, J.J.
2020, Article / Letter to editor (Radiotherapy and Oncology, vol. 143, (2020), pp. 30-36)
Treatable traits qualifying for nonpharmacological interventions in COPD patients upon first referral to a pulmonologist: the COPD sTRAITosphere
Hul, A.J. van 't; Koolen, E.H.; Antons, J.C.; Man, Marianne de; Djamin, R.S.; Veen, J.C. In 't; Heuvel, M. van den ; Borst, Bram van den; Spruit, Martijn A.
2020, Article / Letter to editor (ERJ Open Research, vol. 6, iss. 4, (2020), article 00438-2020)
Antibiotic use and reduced effectiveness of second-line immunotherapy for lung cancer: all the time or just at the start of treatment?
Garde, E.M. van de; Bedaf, L.R. van; Hurkmans, D.P.; Heuvel, M. van den
2020, Article / Letter to editor (Annals of Oncology, vol. 31, iss. 12, (2020), pp. 1779-1780)
Effects of checkpoint inhibitors in advanced non-small cell lung cancer at population level from the National Immunotherapy Registry
Smit, H.J.; Aerts, J.; Heuvel, M. van den ; Hiltermann, T.J.N.; Bahce, I.; Smit, E.F.; Dingemans, A.M.; Hendriks, L.E.; Stigt, J.A.; Schramel, F.M.; Tinteren, H. van; Groen, H.J.M.; of, N.I.R. all participant et al. sine al.
2020, Article / Letter to editor (Lung Cancer, vol. 140, (2020), pp. 107-112)
Barriers and Facilitators for Implementation of a Computerized Clinical Decision Support System in Lung Cancer Multidisciplinary Team Meetings-A Qualitative Assessment
Klarenbeek, S.E. ; Schuurbiers, O.C.J. ; Heuvel, M. van den ; Prokop, M. ; Tummers, M.J.
2020, Article / Letter to editor (Biology, vol. 10, iss. 1, (2020), article 9)
Study protocols of three parallel phase 1 trials combining radical radiotherapy with the PARP inhibitor olaparib
Haan, R. den; Werkhoven, E. van; Heuvel, M. van den ; Peulen, H.M.U.; Sonke, G.S.; Elkhuizen, P.; Brekel, M.W. van den; Tesselaar, M.E.; Vens, C.; Schellens, J.H.; Triest, B. van; Verheij, M. et al. sine al.
2019, Article / Letter to editor (BMC Cancer, vol. 19, (2019), article 901)
Rapid regression of neurological symptoms in patients with metastasised ALK+ lung cancer who are treated with lorlatinib: a report of two cases
Gafer, H.; Waard, Q. de; Compter, A.; Heuvel, M. van den
2019, Article / Letter to editor (BMJ Case Reports, vol. 12, iss. 7, (2019), article e227299)
Risk Assessment After a Severe Hospital-Acquired Infection Associated With Carbapenemase-Producing Pseudomonas aeruginosa
Hopman, J. ; Meijer, C.; Kenters, N.; Coolen, J.P.M. ; Ghamati, M. ; Mehtar, S.; Crevel, R. van ; Morshuis, W.J. ; Verhagen, A.F.T.M. ; Heuvel, M. van den ; Voss, A. ; Wertheim, H.F.L. et al. sine al.
2019, Article / Letter to editor (JAMA Network Open, vol. 2, iss. 2, (2019), pp. e187665)
Pre-hydration in cisplatin-based CCRT: Effects on tumour concentrations and treatment outcome
Aalbersberg, E.A.; Rossi, M.M.; Veen, L.J. de Wit-van der; Walraven, I.; Heuvel, M. van den ; Sonke, J.J.; Belderbos, J.S.; Vogel, W.V.
2019, Article / Letter to editor (Radiotherapy and Oncology, vol. 134, (2019), pp. 30-36)
Cell-free DNA in the supernatant of pleural effusion can be used to detect driver and resistance mutations, and can guide tyrosine kinase inhibitor treatment decisions
Hummelink, K.; Muller, M; Linders, T.C.; Noort, V. van den; Nederlof, P.M.; Baas, P.; Burgers, S.; Smit, E.F.; Meijer, G.A.; Heuvel, M. van den ; Broek, D. van den; Monkhorst, K. et al. sine al.
2019, Article / Letter to editor (ERJ Open Research, vol. 5, iss. 1, (2019), article 00016-2019)
Absence of PD-L1 expression on tumor cells in the context of an activated immune infiltrate may indicate impaired IFN gamma signaling in non-small cell lung cancer
Theelen, Willemijn S.M.E.; Kuilman, Thomas; Schulze, Katja; Zou, Wei; Krijgsman, Oscar; Peters, Dennis D.G.C.; Heuvel, M. van den ; Kowanetz, Marcin
2019, Article / Letter to editor (PLoS One, vol. 14, iss. 5, (2019), article e0216864)
ALK immunohistochemistry positive, FISH negative NSCLC is infrequent, but associated with impaired survival following treatment with crizotinib
Thunnissen, E.; Lissenberg-Witte, B.I.; Heuvel, M. van den ; Monkhorst, K.; Skov, B.G.; Sorensen, J.B.; Drift, M.A. van der ; Looijen-Salamon, M.G. ; Wolf, J.; Pauwels, P.; Smit, E. et al. sine al.
2019, Article / Letter to editor (Lung Cancer, vol. 138, (2019), pp. 13-18)
Glucose and glutamine metabolism in relation to mutational status in NSCLC histological subtypes
Meijer, T.W.H. ; Looijen-Salamon, M.G. ; Lok, J. ; Heuvel, M. van den ; Tops, B.B.; Kaanders, J.H.A.M. ; Span, P.N. ; Bussink, J.
2019, Article / Letter to editor (Thoracic Cancer, vol. 10, iss. 12, (2019), pp. 2289-2299)
Immune checkpoint inhibitors for patients with advanced lung cancer and oncogenic driver alterations: results from the IMMUNOTARGET registry
Mazieres, J.; Drilon, A.; Lusque, A.; Mhanna, L.; Cortot, A.B.; Mezquita, L.; Thai, A.A.; Mascaux, C.; Couraud, S.; Veillon, R.; Heuvel, M. van den ; Neal, J.; Peled, N.; Fruh, M.; Ng, T.L.; Gounant, V.; Popat, S.; Diebold, J.; Sabari, J.; Zhu, V.W.; Rothschild, S.I.; Bironzo, P.; Martinez-Marti, A.; Curioni-Fontecedro, A.; Rosell, R.; Lattuca-Truc, M.; Wiesweg, M.; Besse, B. de; Solomon, B.; Barlesi, F.; Schouten, R.D.; Wakelee, H.; Camidge, D.R.; Zalcman, G.; Novello, S.; Ou, S.I.; Milia, J.; Gautschi, O. et al. sine al.
2019, Article / Letter to editor (Annals of Oncology, vol. 30, iss. 8, (2019), pp. 1321-1328)
Polyfunctional tumor-reactive T cells are effectively expanded from non-small cell lung cancers, and correlate with an immune-engaged T cell profile
Groot, Rosa de; Loenen, M.M. Van; Guislain, A.; Nicolet, B.P.; Heeren, J.J. Freen-Van; Verhagen, O.; Heuvel, M. van den ; Jong, Jeroen de; Burger, P.; Schoot, C.E. van der; Spaapen, R.M.; Amsen, D.; Haanen, J.; Monkhorst, K.; Hartemink, K.J.; Wolkers, M.C. et al. sine al.
2019, Article / Letter to editor (Oncoimmunology, vol. 8, iss. 11, (2019), pp. e1648170)
Prediction of response to anti-PD-1 therapy in patients with non-small-cell lung cancer by electronic nose analysis of exhaled breath
Vries, R. de; Muller, M; Noort, V. van den; Theelen, W.; Schouten, R.D.; Hummelink, K.; Muller, S.H.; Wolf-Lansdorf, M.; Dagelet, J.W.F.; Monkhorst, K.; Zee, A.H. Maitland-van de; Baas, P.; Sterk, P.J.; Heuvel, M. van den et al. sine al.
2019, Article / Letter to editor (Annals of Oncology, vol. 30, iss. 10, (2019), pp. 1660-1666)
Implementation of Novel Molecular Biomarkers for Non-small Cell Lung Cancer in the Netherlands: How to Deal With Increasing Complexity
Broek, D. van den; Hiltermann, T.J.N.; Biesma, B.; Dinjens, W.N.; Hart, N.A. t; Hinrichs, J.W.; Leers, M.P.G.; Monkhorst, K.; Oosterhout, M. van; Scharnhorst, V.; Schuuring, E.; Speel, E.M.; Heuvel, M. van den ; Schaik, R.H. van; Thusen, J. von der; Willems, S.M.; Visser, L de; Ligtenberg, M.J.L. et al. sine al.
2019, Article / Letter to editor (Frontiers in Oncology, vol. 9, (2019), article 1521)
[National variation in molecular diagnostics in metastatic lung cancer].
Kuijpers, C.C.; Heuvel, M. van den ; Overbeek, L.I.H; Slooten, H.J. van; Lindert, A.S.R. van; Damhuis, R.A.; Willems, S.M.
2018, Article / Letter to editor (Nederlands Tijdschrift voor Geneeskunde, vol. 162, (2018), article D1607)
Real life experience with nivolumab for the treatment of non-small cell lung carcinoma: Data from the expanded access program and routine clinical care in a tertiary cancer centre-The Netherlands Cancer Institute
Schouten, R.D.; Muller, M. ; Gooijer, C.J. de; Baas, P.; Heuvel, M. van den
2018, Article / Letter to editor (Lung Cancer, vol. 126, (2018), pp. 210-216)
FOXA1 levels are decreased in pleural breast cancer metastases after adjuvant endocrine therapy, and this is associated with poor outcome.
Schrijver, W.; Schuurman, K.; Rossum, A. van; Droog, M.; Jeronimo, C.; Salta, S.; Henrique, R.; Wesseling, J.; Moelans, C.; Linn, S.C.; Heuvel, M. van den ; Diest, P. van; Zwart, W. et al. sine al.
2018, Article / Letter to editor (Molecular Oncology, vol. 12, iss. 11, (2018), pp. 1884-1894)
Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC.
Antonia, S.J.; Villegas, A.; Daniel, D.; Vicente, D.; Murakami, S.; Hui, R.; Kurata, T.; Chiappori, A.; Lee, K.H.; Wit, M. de; Cho, B.C.; Bourhaba, M.; Quantin, X.; Tokito, T.; Mekhail, T.; Planchard, D.; Kim, Y.C.; Karapetis, C.S.; Hiret, S.; Ostoros, G.; Kubota, K.; Gray, J.E.; Paz-Ares, L.; Castro Carpeno, J. de; Faivre-Finn, C.; Reck, M.; Vansteenkiste, J.; Spigel, D.R.; Wadsworth, C.; Melillo, G.; Taboada, M.; Heuvel, M. van den ; Dennis, P.A.; Ozguroglu, M. et al. sine al.
2018, Article / Letter to editor (The New England Journal of Medicine, vol. 379, iss. 24, (2018), pp. 2342-2350)
Pembrolizumab plus Chemotherapy for Squamous Non-Small-Cell Lung Cancer.
Paz-Ares, L.; Luft, A.; Vicente, D.; Tafreshi, A.; Gumus, M.; Mazieres, J.; Hermes, B.; Cay Senler, F.; Csoszi, T.; Fulop, A.; Rodriguez-Cid, J.; Wilson, J.; Sugawara, S.; Kato, T.; Lee, K.H.; Cheng, Y.; Novello, S.; Halmos, B.; Li, X; Lubiniecki, G.M.; Heuvel, M. van den ; Piperdi, B.; Kowalski, D.M. et al. sine al.
2018, Article / Letter to editor (The New England Journal of Medicine, vol. 379, iss. 21, (2018), pp. 2040-2051)
Improved pharmacodynamic (PD) assessment of low dose PARP inhibitor PD activity for radiotherapy and chemotherapy combination trials
Haan, R. den; Pluim, D.; Triest, B. van; Heuvel, M. van den ; Peulen, H.; Berlo, D. van; George, J.; Verheij, M.; Schellens, J.H.; Vens, C.
2018, Article / Letter to editor (Radiotherapy and Oncology, vol. 126, iss. 3, (2018), pp. 443-449)
Association of molecular status and metastatic organs at diagnosis in patients with stage IV non-squamous non-small cell lung cancer
Kuijpers, C.; Hendriks, L.E.; Derks, J.L.; Dingemans, A.C.; Lindert, A.S.R. van; Heuvel, M. van den ; Damhuis, R.A.; Willems, S.M.
2018, Article / Letter to editor (Lung Cancer, vol. 121, (2018), pp. 76-81)
Immune checkpoint inhibition-related colitis: symptoms, endoscopic features, histology and response to management.
Geukes Foppen, M.H.; Rozeman, E.A.; Wilpe, S. van ; Postma, C.; Snaebjornsson, P.; Thienen, J.V. van; Leerdam, M.E. van; Heuvel, M. van den ; Blank, C.U.; Dieren, J. van; Haanen, J.B.A.G. et al. sine al.
2018, Article / Letter to editor (Esmo Open, vol. 3, iss. 1, (2018), article e000278)
Diagnostic validation and interpretation of longitudinal circulating biomarkers using a biomarker response characteristic plot
Moritz, R.; Muller, M. ; Korse, C.M.; Broek, D. van den; Baas, P.; Noort, V. van den; Heuvel, M. van den ; Rossum, H.H. van
2018, Article / Letter to editor (Clinica Chimica Acta, vol. 487, (2018), pp. 6-14)
Commentary on the MID3 Good Practices Paper
Manolis, E.; Brogren, J.; Cole, S.; Hay, J.L.; Nordmark, A.; Karlsson, K.E.; Lentz, F.; Benda, N.; Wangorsch, G.; Pons, G.; Zhao, W.; Gigante, V.; Serone, F.; Standing, J.F.; Dokoumetzidis, A.; Vakkilainen, J.; Heuvel, M. van den ; Sanjuan, V. Mangas; Taminiau, J.; Kerwash, E.; Khan, D.; Musuamba, F.T.; Rusten, I. Skottheim et al. sine al.
2017, Article / Letter to editor (Cpt Pharmacometrics and Systems Pharmacology, vol. 6, iss. 7, (2017), pp. 416-417)
Swarm Intelligence-Enhanced Detection of Non-Small-Cell Lung Cancer Using Tumor-Educated Platelets
Best, M.G.; Sol, N.; Veld, S.; Vancura, A.; Muller, M. ; Niemeijer, A.N.; Fejes, A.V.; Tjon Kon Fat, L.A.; Huis in 't Veld, A.E.; Leurs, C.; Large, T.Y. Le; Meijer, L.L.; Kooi, I.E.; Rustenburg, F.; Schellen, P.; Verschueren, H.; Post, E.; Wedekind, L.E.; Bracht, J.; Esenkbrink, M.; Wils, L.; Favaro, F.; Schoonhoven, J.D.; Tannous, J.; Meijers-Heijboer, H.; Kazemier, G.; Giovannetti, E.; Reijneveld, J.C.; Idema, S.; Killestein, J.; Heger, M.; Jager, S.C. de; Urbanus, R.T.; Hoefer, I.E.; Pasterkamp, G.; Mannhalter, C.; Gomez-Arroyo, J.; Bogaard, H.J.; Noske, D.P.; Vandertop, W.P.; Broek, D. van den; Ylstra, B.; Nilsson, R.J.; Wesseling, P. ; Karachaliou, N.; Rosell, R.; Lee-Lewandrowski, E.; Lewandrowski, K.B.; Tannous, B.A.; Langen, A.J. de; Smit, E.F.; Heuvel, M. van den ; Wurdinger, T. et al. sine al.
2017, Article / Letter to editor (Cancer Cell, vol. 32, iss. 2, (2017), pp. 238-252.e9)
Phase II Trial of Atezolizumab As First-Line or Subsequent Therapy for Patients With Programmed Death-Ligand 1-Selected Advanced Non-Small-Cell Lung Cancer (BIRCH)
Peters, S.; Gettinger, S.; Johnson, M.L.; Janne, P.A.; Garassino, M.C.; Christoph, D.; Toh, C.K.; Rizvi, N.A.; Chaft, J.E.; Costa, E.; Patel, J.D.; Chow, L.Q.M.; Koczywas, M.; Ho, C.; Fruh, M.; Heuvel, M. van den ; Rothenstein, J.; Reck, M.; Paz-Ares, L.; Shepherd, F.A.; Kurata, T.; Li, Z.; Qiu, J.; Kowanetz, M.; Mocci, S.; Shankar, G.; Sandler, A.; Felip, E. et al. sine al.
2017, Article / Letter to editor (Journal of Clinical Oncology, vol. 35, iss. 24, (2017), pp. 2781-2789)
Targeting RET in Patients With RET-Rearranged Lung Cancers: Results From the Global, Multicenter RET Registry
Gautschi, O.; Milia, J.; Filleron, T.; Wolf, J.; Carbone, D.P.; Owen, D.; Camidge, R.; Narayanan, V.; Doebele, R.C.; Besse, B. de; Remon-Masip, J.; Janne, P.A.; Awad, M.M.; Peled, N.; Byoung, C.C.; Karp, D.D.; Heuvel, M. van den ; Wakelee, H.A.; Neal, J.W.; Mok, T.S.K.; Yang, J.C.H.; Ou, S.I.; Pall, G.; Froesch, P.; Zalcman, G.; Gandara, D.R.; Riess, J.W.; Velcheti, V.; Zeidler, K.; Diebold, J.; Fruh, M.; Michels, S.; Monnet, I.; Popat, S.; Rosell, R.; Karachaliou, N.; Rothschild, S.I.; Shih, J.Y.; Warth, A.; Muley, T.; Cabillic, F.; Mazieres, J.; Drilon, A. et al. sine al.
2017, Article / Letter to editor (Journal of Clinical Oncology, vol. 35, iss. 13, (2017), pp. 1403-1410)
Selumetinib Plus Docetaxel Compared With Docetaxel Alone and Progression-Free Survival in Patients With KRAS-Mutant Advanced Non-Small Cell Lung Cancer: The SELECT-1 Randomized Clinical Trial.
Janne, P.A.; Heuvel, M. van den ; Barlesi, F.; Cobo, M.; Mazieres, J.; Crino, L.; Orlov, S.; Blackhall, F.; Wolf, J.; Garrido, P.; Poltoratskiy, A.; Mariani, G.; Ghiorghiu, D.; Kilgour, E.; Smith, P.; Kohlmann, A.; Carlile, D.J.; Lawrence, D.; Bowen, K.; Vansteenkiste, J. et al. sine al.
2017, Article / Letter to editor (Jama : Journal of the American Medical Association, vol. 317, iss. 18, (2017), pp. 1844-1853)
A Functional Genetic Screen Identifies the Phosphoinositide 3-kinase Pathway as a Determinant of Resistance to Fibroblast Growth Factor Receptor Inhibitors in FGFR Mutant Urothelial Cell Carcinoma.
Wang, L.; Sustic, T.; Leite de Oliveira, R.; Lieftink, C.; Halonen, P.; Ven, M. van de; Beijersbergen, R.L.; Heuvel, M. van den ; Bernards, R.; Heijden, M.S. van der
2017, Article / Letter to editor (European Urology, vol. 71, iss. 6, (2017), pp. 858-862)
A randomized controlled trial comparing indwelling pleural catheters with talc pleurodesis (NVALT-14).
Boshuizen, R.C.; Vander Noort, V.; Burgers, J.A.; Herder, G.J.M.; Hashemi, S.M.; Hiltermann, T.J.N.; Kunst, P.W.; Stigt, J.A.; Heuvel, M. van den
2017, Article / Letter to editor (Lung Cancer, vol. 108, (2017), pp. 9-14)
Durvalumab after Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer.
Antonia, S.J.; Villegas, A.; Daniel, D.; Vicente, D.; Murakami, S.; Hui, R.; Yokoi, T.; Chiappori, A.; Lee, K.H.; Wit, M. de; Cho, B.C.; Bourhaba, M.; Quantin, X.; Tokito, T.; Mekhail, T.; Planchard, D.; Kim, Y.C.; Karapetis, C.S.; Hiret, S.; Ostoros, G.; Kubota, K.; Gray, J.E.; Paz-Ares, L.; Castro Carpeno, J. de; Wadsworth, C.; Melillo, G.; Jiang, H.; Huang, Y.; Dennis, P.A.; Ozguroglu, M.; Heuvel, M. van den ; et al. et al. sine al.
2017, Article / Letter to editor (The New England Journal of Medicine, vol. 377, iss. 20, (2017), pp. 1919-1929)
First-Line Nivolumab in Stage IV or Recurrent Non-Small-Cell Lung Cancer.
Carbone, D.P.; Reck, M.; Paz-Ares, L.; Creelan, B.; Horn, L.; Steins, M.; Felip, E.; Heuvel, M. van den ; Ciuleanu, T.E.; Badin, F.; Ready, N.; Hiltermann, T.J.N.; Nair, S.; Juergens, R.; Peters, S.; Minenza, E.; Wrangle, J.M.; Rodriguez-Abreu, D.; Borghaei, H.; umenschein GR, J.r. Bl; Villaruz, L.C.; Havel, L.; Krejci, J.; rral Jaime, J. Co; Chang, H.; Geese, W.J.; Bhagavatheeswaran, P.; Chen, A.C.; Socinski, M.A. et al. sine al.
2017, Article / Letter to editor (The New England Journal of Medicine, vol. 376, iss. 25, (2017), pp. 2415-2426)
Implementation of a Multicenter Biobanking Collaboration for Next-Generation Sequencing-Based Biomarker Discovery Based on Fresh Frozen Pretreatment Tumor Tissue Biopsies.
Bins, S.; Cirkel, G.A.; Gadellaa-van Hooijdonk, C.G.M.; Weeber, F.; Numan, I.J.; Bruggink, A.H.; Diest, P.J. van; Willems, S.M.; Veldhuis, W.B.; Heuvel, M. van den ; Knegt, R.J. de; Koudijs, M.J.; Werkhoven, E. van; Mathijssen, R.H.; Cuppen, E.; Sleijfer, S.; Schellens, J.H.; Voest, E.E.; Langenberg, M.H.; Jonge, M.J. de; Steeghs, N.; Lolkema, M.P. et al. sine al.
2017, Article / Letter to editor (Oncologist, vol. 22, iss. 1, (2017), pp. 33-40)
Polymerization-induced color changes of polydiacetylene-containing liposomes and peptide amphiphile fibers
Ramakers, B.E.I.; Heuvel, M. van den ; Spithas, N.T.I.; Brinkhuis, R.P.; Hest, J.C.M. van ; Lowik, D.W.P.M.
2012, Article / Letter to editor (Langmuir, vol. 28, iss. 4, (2012), pp. 2049-2055)

Now showing items 1-50 of 60

Radboud Repository

Browsing by Author "Heuvel, M. van den"

Search Repository

Browse

All of Repository